Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Recruiting 3Completed 2

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Other neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 427Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 195Ovarian Neoplasms 172Recurrence 149Lung Neoplasms 149Prostatic Neoplasms 147Pancreatic Neoplasms 142Multiple Myeloma 134Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Endometrial Neoplasms 115Leukemia, Myeloid, Acute 114Advanced Solid Tumors 113Advanced Solid Tumor 109Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Uterine Cervical Neoplasms 87Small Cell Lung Carcinoma 87Lymphoma, Non-Hodgkin 85Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 69Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Esophageal Neoplasms 62

Interventions

Watchful Waiting 1Transurethral Resection of Prostate 1Pregnancy Tests 1Human Papillomavirus DNA Tests 1Drug Therapy 1Colposcopy 1Biopsy 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Uterine Cervical Diseases × Clear all
NCT06952660 2026-04-20

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Pfizer

Phase 4 Recruiting
100 enrolled
Gynecologic

Urogenital Diseases, Uterine Cervical Diseases, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Neoplasms by Site, Uterine Diseases, Uterine Neoplasms, Female Urogenital Diseases

NCT06815939 2026-01-29

OPTICS

DL Analytics

Phase NA Recruiting
10,000 enrolled
GynecologicOther neoplasm

Urogenital Diseases, Genital Diseases, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Female, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Precancerous Conditions, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

NCT06692166 2024-11-22

A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer

Mabwell (Shanghai) Bioscience Co., Ltd.

Phase 3 Recruiting
420 enrolled
Gynecologic

Uterine Cervical Diseases, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Uterine Diseases, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡